NuVasive, Inc.

NASDAQ: NUVA
$55.76
-$0.38 (-0.7%)
Closing price May 26, 2022
The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap and Western Digital.
Each year, the analysts at RBC come out with a detailed list of smaller companies they feel are targets for acquisitions. These four health care candidates look extremely attractive.
With earnings for the third quarter wrapping up, executives and 10% owners that are insiders are once again free to trade shares, and volume is starting to pick up again.
A new research report from Jefferies notes that when price momentum has been as bad as it has been recently, it tends to rebound in a big way.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include EMC, MetLife, Pandora Media, Whiting Petroleum, Yelp, Mosaic and Oasis Petroleum.
With an aging population, and larger health care companies looking to add new technologies and capabilities, the chances for mergers and acquisitions activity to jump are very real.
Tuesday’s top analyst upgrades, downgrades and initiations include CBS, Cisco, Comerica, Twitter, FedEx, Illumina, Linn Energy and NuVasive.
Source: ThinkstockNuVasive, Inc. (NASDAQ: NUVA) is proving to be one of the key winners from earnings. On top of gains nearing 10% after its report, investors might want to consider that NuVasive...
Source: Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet another instance where investors proved that they want to buy...
Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, Cisco Systems, Frontier Communications, Marvell Technology, Yingli Green Energy and AT&T.
24/7 Wall St. has screened the RBC list of potential takeover candidates for the higher profile and more well-known health care stocks.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Tuesday, September 30, 2014.
Here are four top medical device makers that the Leerink team thinks make sense as potential takeover candidates, but also have more than enough merit to stand on their own.
Source: ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further...
The stock market is up Wednesday, with the Dow Jones Industrial Average up 0.61%, the Nasdaq up 0.54% and the S&P 500 up 0.46%. Today’s winners include a medical diagnostic developer who...